Relay Therapeutics, Inc. (RLAY)
14.42
+0.25
(+1.76%)
USD |
NASDAQ |
May 27, 16:00
14.42
0.00 (0.00%)
After-Hours: 16:29
Relay Therapeutics Cash from Investing (Quarterly) : 32.90M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Tyra Biosciences, Inc. | -120.24M |
| Spyre Therapeutics, Inc. | 56.58M |
| Revolution Medicines, Inc. | 172.62M |
| Tango Therapeutics, Inc. | 9.635M |
| Summit Therapeutics, Inc. | -0.238M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -51.11M |
| Cash from Financing (Quarterly) | 138.78M |
| Free Cash Flow | -213.38M |
| Free Cash Flow Per Share (Quarterly) | -0.2842 |
| Free Cash Flow to Equity (Quarterly) | -50.22M |
| Free Cash Flow to Firm (Quarterly) | -51.11M |
| Free Cash Flow Yield | -8.49% |